Evidence map›Paper›PMID 39869488›Full record

ReviewMicrobial biotechnology2025

Microbes as Resources to Remove PPCPs and Improve Water Quality.

Francesca Demaria, Marcel Suleiman, Philippe Corvini, Pilar Junier

Abstract readReview
In one paragraph

Review in Microbial biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Francesca DemariaInstitute for Chemistry and Bioanalytics, University of Applied Sciences and Arts Northwestern, Muttenz, Switzerland.
Marcel SuleimanInstitute for Chemistry and Bioanalytics, University of Applied Sciences and Arts Northwestern, Muttenz, Switzerland.
Philippe CorviniInstitute for Chemistry and Bioanalytics, University of Applied Sciences and Arts Northwestern, Muttenz, Switzerland.ORCID 0000-0002-2991-5031
Pilar JunierLaboratory of Microbiology, Institute of Biology, University of Neuchatel, Neuchatel, Switzerland.ORCID 0000-0002-8618-3340

Funding

European Commission 101060625
6 · The paper itself

Abstract

The inadequate removal of pharmaceuticals and personal care products (PPCPs) by traditional wastewater treatment plants (WWTPs) poses a significant environmental and public health challenge. Residual PPCPs find their way into aquatic ecosystems, leading to bioaccumulation in aquatic biota, the dissemination of antibiotic resistance genes (ARGs), and contamination of both water sources and vegetables. These persistent pollutants can have negative effects on human health, ranging from antibiotic resistance development to endocrine disruption. To mitigate these risks, there is a growing interest in exploiting microorganisms and their enzymes for bioremediation purposes. By harnessing the metabolic capabilities of microbial communities, PPCPs can be efficiently degraded, transformed, or sequestered in water systems. Additionally, microbial communities exhibit remarkable adaptability and resilience to diverse PPCP contaminants, further underscoring their potential as sustainable and cost-effective solutions for water treatment. This review explores the promise of microbial bioremediation as an approach to addressing the complex challenges posed by persistent PPCP contamination, emphasising its potential to safeguard both environmental integrity and human well-being.

Indexed as

BacteriaCosmeticsWater Pollutants, ChemicalWater PurificationWater QualityBiodegradation, EnvironmentalHumansPharmaceutical PreparationsWastewaterCosmeticsPharmaceutical PreparationsWastewaterWater Pollutants, Chemical

Identifiers

PMID39869488
PMCPMC11771509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.